PRIA Logo™
MarylandSB 09872026 Regular SessionSenate

Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising

Sponsored By: Karen Lewis Young (Democratic)

In Committee

Taxes - IncomePublic HealthAdvertisingComptrollerCorporations -see also- Municipal Corps; Public Corps & InstDigital ImagesDrugs -see also- Cannabis; ControlDangSubst; Pharm; etc.Electronic CommunicationExemptionsHealth Benefit ExchangeHealth Insurance -see also- ACA; HMOs; MCOsIncome TaxInternet -see also- Internet AccessMobile DevicesPostal ServiceRadioRevenue and Taxes -see also- (specific tax)Signs and BillboardsSocial MediaState Aid -see also- Public BenefitsTelecommunicationsTelephonesTelevision -see also- Cable Television

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Karen Lewis Young

    Democratic • Senate

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Hearing 3/11 at 1:00 p.m.

    3/5/2026Senate

  2. Rereferred to Budget and Taxation

    3/4/2026Senate

  3. First Reading Senate Rules

    2/15/2026Senate

Bill Text

  • First Reading

    2/15/2026

    PDF

Related Bills

Back to State Legislation